Captor Therapeutics (WAR:CTX) FCF Margin % : -164.53% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Captor Therapeutics's Free Cash Flow for the three months ended in Sep. 2024 was zł-5.81 Mil. Captor Therapeutics's Revenue for the three months ended in Sep. 2024 was zł3.53 Mil. Therefore, Captor Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was -164.53%.

As of today, Captor Therapeutics's current FCF Yield % is -26.26%.

The historical rank and industry rank for Captor Therapeutics's FCF Margin % or its related term are showing as below:

WAR:CTX' s FCF Margin % Range Over the Past 10 Years
Min: -13943.75 Med: -418.22 Max: 442.41
Current: -212.64

During the past 7 years, the highest FCF Margin % of Captor Therapeutics was 442.41%. The lowest was -13943.75%. And the median was -418.22%.

WAR:CTX's FCF Margin % is ranked worse than
58.26% of 999 companies
in the Biotechnology industry
Industry Median: -121.51 vs WAR:CTX: -212.64

Captor Therapeutics FCF Margin % Historical Data

The historical data trend for Captor Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics FCF Margin % Chart

Captor Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-842.60

-260.32

-418.22

Captor Therapeutics Quarterly Data
	Dec18	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-182.52	-270.27	-227.59	-156.53	-164.53

Competitive Comparison of Captor Therapeutics's FCF Margin %

For the Biotechnology subindustry, Captor Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Captor Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Captor Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Captor Therapeutics's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Captor Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Captor Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-55.209	/	13.201
	=	-418.22 %

Captor Therapeutics's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-5.808	/	3.53
	=	-164.53 %

Captor Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.captortherapeutics.com

Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics Headlines

No Headlines